Endometrial cancer is a type of uterine cancer that begins when cells in the endometrium (inner lining of the uterus) grow out of control. Surgery is the most common treatment for the majority of people with endometrial cancer. You may need additional treatments based on the results of other tests.
This article will explain seven treatment options for endometrial cancer, including surgery, radiation therapy, and hormone therapy, so you can better understand your care choices.
There is no single treatment that works best for everyone with endometrial cancer. A gynecologic oncologist (a doctor who specializes in cancers of the female reproductive system) can help you choose the best treatment for you based on several factors, including:
Potential side effects may also be a factor in which treatment option is most suitable for you. Your oncologist can share which side effects are possible with each treatment, how common or rare they are, and ways to manage them. Together, you can discuss the potential risks and benefits of each treatment and decide on the best treatment plan for you.
Continue reading to learn more about the different treatment options for endometrial cancer.
Surgery to remove the cancer is usually the first endometrial cancer treatment for most people.
It may be the only treatment needed for early-stage endometrial cancers.
There are several types of surgical procedures your cancer care team may recommend:
A BSO is usually done at the same time as a hysterectomy. If you haven’t gone through menopause, your cancer care team may suggest a hysterectomy alone.
Depending on the type and grade of your cancer, your cancer care team may recommend removing nearby lymph nodes during a hysterectomy or BSO. Lymph nodes are small, bean-shaped structures in the immune system that help filter harmful substances and fight infections. Testing lymph nodes can determine if the cancer has metastasized (spread), which is essential for staging and choosing effective treatments.
If your cancer has spread throughout the abdomen (stomach area), you may need debulking surgery. Debulking aims to reduce the size of a tumor when it cannot be completely removed. This procedure can help other treatments work better.
Removing your uterus with any type of hysterectomy will cause infertility. This means you won’t be able to become pregnant in the future. If you have your ovaries removed with a BSO, you’ll start menopause (if you haven’t already).
If you have your lymph nodes removed, it can cause a buildup of fluid and swelling in the area called lymphedema.
Radiation therapy uses high-energy X-rays or other radiation to kill cancer cells. It is often started about four to six weeks after surgery, giving your body time to heal.
In some cases, radiation therapy may be given before surgery to shrink very large tumors, making them easier to remove. Radiation therapy may also be given as the main treatment, instead of surgery, for people who aren’t healthy enough for surgery.
There are two main types of radiation therapy used for endometrial cancer — brachytherapy and external beam radiation therapy.
In brachytherapy (internal radiation therapy), a small cylinder with radioactive material is placed inside the vagina. This limits radiation exposure to nearby healthy tissues, like the bladder and rectum. Treatments are done in a hospital or treatment center and may last a few minutes to a few days, depending on the dose and type.
External beam radiation therapy uses a machine outside of your body to focus radiation on the affected area. This type of radiation is usually given five days a week for up to six weeks.
In some cases, you may receive both brachytherapy and external beam radiation therapy for the best results.
In the short term, radiation for endometrial cancer may cause side effects including a skin rash or irritation to the bladder, rectum, or vagina. In the longer term, it may leave you with a higher risk for:
Chemotherapy (chemo) uses drugs to kill cancer cells. It’s often used to treat advanced endometrial cancer or high-grade early-stage endometrial cancer (cancers that are more aggressive).
Chemo drugs for endometrial cancer are usually given intravenously (directly into a vein), though some for later-stage cancer are taken orally (by mouth). Chemotherapy is usually given in cycles. Each cycle involves a period of active treatment followed by a period to rest and recover.
Chemotherapy for endometrial cancer often involves a combination of two or more drugs. Common regimens include:
Read more about chemotherapy for endometrial cancer and its potential side effects.
Hormone therapy uses drugs that mimic or block hormones to slow the growth of endometrial cancer. This treatment is often combined with chemotherapy for people with advanced endometrial cancer or recurrent endometrial cancer (cancer that returns after treatment). Progestins and drugs that block or lower estrogen levels are the main types of hormone therapy used for endometrial cancer.
Progestins are the most common type of hormone therapy used to slow the growth of endometrial cancer. Medroxyprogesterone acetate (Provera) and megestrol acetate (Megace ES) are the most common types of progestins. These drugs can be taken as a pill, a liquid, or an injection.
Some types of early endometrial cancers can be treated with an intrauterine device (IUD) inserted into the uterus that releases a progestin called levonorgestrel.
Progestins may be the main treatment for individuals with early-stage endometrial cancer who want to have children in the future.
Other hormone treatments for endometrial cancer work by blocking the effect of estrogen or decreasing its production. While these therapies aren’t approved by the U.S. Food and Drug Administration (FDA) specifically for treating endometrial cancer, they are sometimes prescribed “off-label.” These treatments include:
Hormone therapy for endometrial cancer largely mirror symptoms of menopause. They may include:
Immunotherapy uses your own immune system to kill cancer cells. This type of treatment may be recommended for people with advanced or recurrent endometrial cancer or if other treatments, like surgery and radiation, aren’t possible.
Immune checkpoint inhibitors (ICIs) are the main type of immunotherapy used to treat endometrial cancer. These drugs block proteins that stop the immune system from attacking cancer cells, allowing it to target and destroy them more effectively. Examples of ICIs include:
Immune checkpoint inhibitors are generally given by IV every three to six weeks.
Some immune checkpoint inhibitors work best against cancer cells with specific biomarkers. Talk to your cancer care team to find out if your cancer cells have been tested for these biomarkers.
Immunotherapies can cause a wide range of side effects depending on which type is used. Common side effects include:
In rare cases, immunotherapies may cause an infusion reaction (like an allergic reaction) or an autoimmune reaction. These are more serious problems that will require medical treatment.
Targeted therapies use drugs to block specific proteins or genetic changes that help cancer cells grow and spread. This treatment is typically used for advanced or recurrent endometrial cancer. It may be given alone or with other treatments, such as chemotherapy or immunotherapy.
The use of targeted therapy drugs for endometrial cancer is relatively new. As of December 2024, lenvatinib (Lenvima) is the only targeted therapy approved by the FDA for treat endometrial cancer. Lenvatinib is a kinase inhibitor that works by targeting proteins that cancer cells use to grow. It can also stop the formation of new blood vessels that help tumors grow. You take lenvatinib once a day as a pill.
Doctors will sometimes prescribe certain targeted therapies off-label for endometrial cancer, including:
In general, side effects of targeted therapy for cancer can include:
Clinical trials are research studies that investigate whether a new treatment for endometrial cancer is safe and effective. The American Cancer Society recommends that women with stage 4 or recurrent endometrial cancer consider joining a clinical trial. Talk to your cancer care team to find out if you qualify for any clinical trials.
Endometrial cancer treatment isn’t one-size-fits-all — it depends on the type and stage of your cancer, your health, and your personal preferences, like preserving fertility. Work with your gynecologic oncologist to create a personalized plan that fits your needs.
It’s important to stay proactive by informing your doctor about side effects or changes during treatment. Following your treatment plan, attending follow-ups, and staying in touch with your care team will give you the best chance for success. Remember, your care team is there to support you.
On MyEndometrialCancerTeam, the social network for people living with endometrial cancer and their loved ones, members come together to ask questions, give advice, and share their experiences with life and care challenges related to life with endometrial cancer.
Have you been diagnosed with endometrial cancer? What treatments are you using to manage your condition? Share your experience in the comments below, or post to your Activities feed.
Get updates directly to your inbox.
Become a member to get even more:
We'd love to hear from you! Please share your name and email to post and read comments.
You'll also get the latest articles directly to your inbox.